Silicon Laboratories Inc. (SLAB) Profit Margins
Over the twelve months to 2026-07-04, Silicon Laboratories Inc. (SLAB) had gross margin 60.6%, operating margin -5.1%, net margin -4.6%, free cash flow margin -1.1%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-07-04 · read by EquiReason
SLABSilicon Laboratories Inc.Follow SLAB — free
—
Price chart with a free account
- Market cap
- 7.4B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2010 Jan 11 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Jan 15 | FY2015 Jan 16 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Jan 21 | FY2021 Jan 22 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Jan 26 | TTM Jul 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 65.7% | 60.7% | 60.0% | 60.8% | 61.0% | 59.1% | 60.4% | 59.1% | 60.1% | 59.1% | 57.7% | 59.0% | 62.7% | 58.9% | 53.4% | 58.2% | 60.6% | |
| Operating margin | 17.6% | 10.2% | 15.2% | 11.1% | 8.3% | 5.0% | 9.5% | 11.1% | 9.8% | -18.7% | -21.0% | -4.6% | 11.6% | -3.1% | -28.3% | -9.0% | -5.1% | |
| Net margin | 14.8% | 7.2% | 11.3% | 8.6% | 6.1% | 4.6% | 8.8% | 6.1% | 9.6% | 4.1% | 2.5% | 293.7% | 8.9% | -4.4% | -32.7% | -8.3% | -4.6% | |
| FCF margin | 21.1% | 16.3% | -0.9% | 18.9% | 20.3% | 14.6% | 16.9% | 22.4% | 15.9% | 30.2% | 22.8% | 8.5% | 11.2% | -6.8% | -4.4% | 7.9% | -1.1% |
USD billions · SEC XBRL
Silicon Laboratories Inc. — questions
- What is Silicon Laboratories Inc.'s gross margin?
- 60.6% over the twelve months to 2026-07-04.
- What is Silicon Laboratories Inc.'s operating margin?
- -5.1% over the twelve months to 2026-07-04.
- What is Silicon Laboratories Inc.'s net profit margin?
- -4.6% over the twelve months to 2026-07-04.
Every figure on this page comes from Silicon Laboratories Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.